Oramed Pharmaceuticals Inc. (ORMP) is a publicly traded Healthcare sector company. As of June 17, 2026, ORMP trades at $3.83 with a market cap of $157.16M and a P/E ratio of 2.49. ORMP moved +2.12% today. Year to date, ORMP is +29.55%; over the trailing twelve months it is +74.54%. Its 52-week range spans $1.82 to $5.01. Rallies surfaces ORMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ORMP shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $3.83 |
| Market Cap | $157.16M |
| P/E Ratio | 2.49 |
| EPS | $1.53 |
| Dividend Yield | 0.25% |
| 52-Week High | $5.01 |
| 52-Week Low | $1.82 |
| Volume | 129.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.00M |
| Net Income | $64.02M |
| Gross Margin | 0.65% |
ORMP analyst coverage data. Average price target: $0.00.